KATHRYN WATT: Open Payments
NPI 1154446862 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,876 in 123 payments from 20 companies in 2025. Trend: 2023 $803 · 2024 $1,575 · 2025 $2,876
Food & beverage: $2,732Education: $143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $694 |
| Madrigal Pharmaceuticals | 17 | $505 |
| Janssen Biotech, Inc. | 15 | $408 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $248 |
| Ardelyx, Inc. | 8 | $180 |
| Aimmune Therapeutics, Inc. | 7 | $140 |
| Phathom Pharmaceuticals, Inc. | 11 | $116 |
| PFIZER INC. | 4 | $78 |
| GENZYME CORPORATION | 2 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, Linzess, ENTYVIO, IBSRELA, DUPIXENT, ZENPEP.
Industry payments across GA — which companies pay providers there.
